1. Home
  2. FUTU vs BIO Comparison

FUTU vs BIO Comparison

Compare FUTU & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUTU
  • BIO
  • Stock Information
  • Founded
  • FUTU 2011
  • BIO 1952
  • Country
  • FUTU Hong Kong
  • BIO United States
  • Employees
  • FUTU N/A
  • BIO N/A
  • Industry
  • FUTU Investment Bankers/Brokers/Service
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • FUTU Finance
  • BIO Industrials
  • Exchange
  • FUTU Nasdaq
  • BIO Nasdaq
  • Market Cap
  • FUTU 26.1B
  • BIO 7.7B
  • IPO Year
  • FUTU 2019
  • BIO N/A
  • Fundamental
  • Price
  • FUTU $180.67
  • BIO $280.62
  • Analyst Decision
  • FUTU Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • FUTU 5
  • BIO 4
  • Target Price
  • FUTU $205.60
  • BIO $333.50
  • AVG Volume (30 Days)
  • FUTU 2.2M
  • BIO 225.4K
  • Earning Date
  • FUTU 08-20-2025
  • BIO 10-29-2025
  • Dividend Yield
  • FUTU 1.08%
  • BIO N/A
  • EPS Growth
  • FUTU 86.80
  • BIO N/A
  • EPS
  • FUTU 7.17
  • BIO 11.49
  • Revenue
  • FUTU $2,051,001,847.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • FUTU $53.57
  • BIO $2.12
  • Revenue Next Year
  • FUTU $10.59
  • BIO $2.90
  • P/E Ratio
  • FUTU $25.91
  • BIO $24.23
  • Revenue Growth
  • FUTU 69.56
  • BIO N/A
  • 52 Week Low
  • FUTU $57.48
  • BIO $211.43
  • 52 Week High
  • FUTU $199.86
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • FUTU 52.09
  • BIO 48.48
  • Support Level
  • FUTU $178.78
  • BIO $276.52
  • Resistance Level
  • FUTU $194.41
  • BIO $298.00
  • Average True Range (ATR)
  • FUTU 8.08
  • BIO 7.47
  • MACD
  • FUTU -2.02
  • BIO -2.84
  • Stochastic Oscillator
  • FUTU 21.19
  • BIO 16.83

About FUTU Futu Holdings Limited

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and the United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services, and interest income.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: